Frank Gargasz
Clinical Nurse Specialist · Boardman, OHNPI 1720398134
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,150 of the $37,430 with a category attached, or 93.9%. Medtronic accounts for 96.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $14,698 and has fallen 94.8% since, to $764 in 2025. Among clinical nurse specialist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $267.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$36K
- Insulet Corporation$709
- Novo Nordisk$172
- Dexcom, Inc.$65
- Lilly USA, LLC$55
- Corcept Therapeutics$42
- plus $119 from 5 others
What the payments were for
- Speaking & faculty fees$35,15094%
- Food & beverage$2,2696%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 74 | $36,268 |
| Insulet Corporation | 39 | $709 |
| Novo Nordisk | 11 | $172 |
| Dexcom, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $55 |
| Corcept Therapeutics | 3 | $42 |
| Bayer | 2 | $36 |
| Ascensia Diabetes Care US Inc. | 2 | $32 |
| BETA Bionics, Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 770G$14,671
- MINIMED 780G$14,120
- Minimed 770G System$6,461
How this compares
$37,430 in reported general payments places this provider in the 95th percentile of 97 clinical nurse specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 435 | $595,714 |
| TrulicityDulaglutide | 282 | $390,221 |
| JardianceEmpagliflozin | 262 | $267,656 |
| MounjaroTirzepatide | 81 | $108,731 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 61 | $73,947 |
| Humulin R U-500Insulin Regular, Human | 27 | $65,089 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 39 | $58,313 |
| Humalog Kwikpen U-100Insulin Lispro | 113 | $40,706 |
| FarxigaDapagliflozin Propanediol | 33 | $39,001 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 139 | $38,422 |
| Tresiba Flextouch U-200Insulin Degludec | 35 | $38,085 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 274 | $37,724 |
| Tresiba Flextouch U-100Insulin Degludec | 59 | $36,155 |
| TradjentaLinagliptin | 29 | $34,470 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $24,745 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $172 | $644,214492 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $55 | $524,999492 claims |
| Sanofi-aventis U.S. LLCLantus, Admelog | $11 | $13,67747 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 97 clinical nurse specialist providers in Ohio.
Other clinical nurse specialist in Boardman
- Nancy AlbertChesterland$114K
- Jennifer WoodsAkron$19K
- Nancy BairCleveland$13K
- Maria HeldCleveland$7K
- Rebecca ThomasAkron$6K
- Marie NameyCleveland$5K
- Nancy Hampton-JonesDayton$5K
- Linda DebalzoBeachwood$4K
- Kimberly SprottColumbus$4K
- Deborah BrayCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.